01483nam 2200409Ia 450 991069873250332120090421140021.0(CKB)5470000002396532(OCoLC)318914513(EXLCZ)99547000000239653220090421d2008 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] nucleic acid testing (NAT) to reduce the possible risk of parvovirus B19 transmission by plasma-derived productsRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2008]i, 5 pages digital, PDF fileTitle from PDF title page (viewed on Apr. 21, 2009)."Draft guidance.""July 2008."Includes bibliographical references (pages 4-5).Guidance for industry Nucleic acidsTestingParvovirus infectionsPreventionPlasma productsNucleic acidsTesting.Parvovirus infectionsPrevention.Plasma products.Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698732503321Guidance for industry3434577UNINA